These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 33704561)
21. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674 [TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric study. Livin M; Leonard D; Bachmann R; Remue C; Barbois S; Cotte E; Van Den Eynde M; De Cuyper A; Sinapi I; Van Maanen A; Kartheuser A Acta Gastroenterol Belg; 2022; 85(4):573-579. PubMed ID: 36566366 [TBL] [Abstract][Full Text] [Related]
23. Cytoreduction and HIPEC for Gastric Carcinomatosis: Multi-institutional Analysis of Two Phase II Clinical Trials. Green BL; Blumenthaler AN; Gamble LA; McDonald JD; Robinson K; Connolly M; Epstein M; Hernandez JM; Blakely AM; Badgwell BD; Davis JL Ann Surg Oncol; 2023 Mar; 30(3):1852-1860. PubMed ID: 36348206 [TBL] [Abstract][Full Text] [Related]
24. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. Burnett A; Lecompte MA; Trabulsi N; Dubé P; Gervais MK; Trilling B; Cloutier AS; Sideris L World J Surg Oncol; 2019 May; 17(1):83. PubMed ID: 31092250 [TBL] [Abstract][Full Text] [Related]
25. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis. Shaltiel T; Solomon D; Pletcher ER; Golas BJ; Magge DR; Sarpel U; Labow DM; Cohen NA Surg Endosc; 2022 Aug; 36(8):6153-6161. PubMed ID: 35080674 [TBL] [Abstract][Full Text] [Related]
26. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center. Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer. Lee TY; Hsu CH; Fan HL; Liao GS; Chen TW; Chan DC Eur J Surg Oncol; 2022 Sep; 48(9):1972-1979. PubMed ID: 35508455 [TBL] [Abstract][Full Text] [Related]
28. Pelvic exenteration, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: experience and outcomes from an exenterative and peritonectomy unit. Flood MP; Waters PS; Soucisse M; Ramsay R; Michael M; McCormick JJ; Warrier S; Heriot A Langenbecks Arch Surg; 2021 Dec; 406(8):2807-2815. PubMed ID: 34495403 [TBL] [Abstract][Full Text] [Related]
29. Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis. Martins M; Santos-Sousa H; Araújo F; Nogueiro J; Sousa-Pinto B Ann Surg Oncol; 2022 Nov; 29(12):7528-7537. PubMed ID: 35930109 [TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer. Akturk Esen S; Ozgun YM; Hasturk D; Ucar G; Bostanci EB; Sendur MAN; Uncu D Oncology; 2023; 101(5):321-327. PubMed ID: 36809752 [TBL] [Abstract][Full Text] [Related]
31. Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Mangieri CW; Moaven O; Valenzuela CD; Erali RA; Votanopoulos KI; Shen P; Levine EA Ann Surg Oncol; 2022 Apr; 29(4):2641-2648. PubMed ID: 35022900 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Yildirim Y; Sokmen S; Cevlik AD; Bisgin T; Manoglu B; Obuz F Langenbecks Arch Surg; 2023 May; 408(1):182. PubMed ID: 37148400 [TBL] [Abstract][Full Text] [Related]
33. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O; Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751 [TBL] [Abstract][Full Text] [Related]
34. Peritoneal carcinomatosis index and overall survival in patients taken to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. López-Basave HN; Morales-Vázquez F; Herrera-Gómez Á; Miranda-Devora G; Padilla-Rosciano AE; Castillo-Morales C; Paleta-Torres CA; Vázquez-Cortes E Cir Cir; 2023; 91(2):195-199. PubMed ID: 37084306 [TBL] [Abstract][Full Text] [Related]
35. Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials. Stefano M; Perrina D; Vallicelli C; Ansaloni L; Fugazzola P; Coccolini F; Agnoletti V; Frassineti GL; Passardi A; Tamberi S; Framarini M; Tassinari D; Matteucci L; Sturaro C; Gallo G; Catena F J Gastrointest Surg; 2024 Jul; 28(7):1185-1193. PubMed ID: 38599315 [TBL] [Abstract][Full Text] [Related]
36. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'. Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F; Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569 [TBL] [Abstract][Full Text] [Related]
37. Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review. Chen C; Justo M; Gangi A Chin Clin Oncol; 2023 Dec; 12(6):68. PubMed ID: 38195075 [TBL] [Abstract][Full Text] [Related]
38. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer. Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829 [TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: A retrospective cohort study. Feng F; Gao Q; Wu Y; Liu C; Yu Y; Li B; Chu K; Yi B; Cheng Q; Jiang X Eur J Surg Oncol; 2021 Sep; 47(9):2363-2368. PubMed ID: 34119376 [TBL] [Abstract][Full Text] [Related]
40. Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer. Di Giorgio A; Santullo F; Attalla El Halabieh M; Lodoli C; Abatini C; Calegari MA; Martini M; Rotolo S; Pacelli F J Gastrointest Surg; 2021 Oct; 25(10):2649-2659. PubMed ID: 34244953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]